SCHEMBL2833329

SCHEMBL2833329

COC(=O)CCC(=O)Nc1ccc(C(=O)NNC(=O)O)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.64
HTT P42858 3/20 0.60
ALDH1A1 P00352 2/20 0.60
HPGD P15428 1/20 0.60
L3MBTL1 Q9Y468 2/20 0.60
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
CYP1A2 P05177 1/20 0.59
ATM Q13315 1/20 0.59
MAPT P10636 4/20 0.57
RAB9A P51151 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
TDP1 Q9NUW8 3/20 0.52
POLB P06746 2/20 0.52
CTSL P07711 1/20 0.51
PTPRC P08575 1/20 0.51
PTPN13 Q12923 1/20 0.51
CYP2C9 P11712 1/20 0.50
LMNA P02545 1/20 0.50
DUSP3 P51452 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2836609 0.92 TDP1 (0.56) GAAHTTALDH1A1HPGDL3MBTL1
SCHEMBL2834485 0.91 HDAC8 (0.58) GAAHTTALDH1A1L3MBTL1MEN1
SCHEMBL2839593 0.83 HPGD (0.57) GAAHTTALDH1A1HPGDL3MBTL1
SCHEMBL14570553 0.80 HTT (0.73) GAAHTTALDH1A1HPGDL3MBTL1
SCHEMBL5346635 0.78 ALDH1A1 (0.74) GAAHTTALDH1A1HPGDL3MBTL1
SCHEMBL563042 0.77 MEN1 (0.72) GAAALDH1A1HPGDL3MBTL1MEN1
SCHEMBL6416347 0.77 GAA (0.53) GAAHTTALDH1A1HPGDL3MBTL1
SCHEMBL2832414 0.76 PTPN1 (0.68) GAAHTTALDH1A1HPGDL3MBTL1
SCHEMBL2835013 0.76 HDAC8 (0.50) GAAHTTALDH1A1HPGDL3MBTL1
SCHEMBL2835595 0.75 HDAC8 (0.52) GAAHTTALDH1A1HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168101-A1 OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2010-07-01 US claimed
US-20100168101-A1 OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2010-07-01 US disclosed
US-7696231-B2 Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPs) LABORATOIRES SERONO SA (CH) 2010-04-13 US disclosed
US-20050043388-A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. 2005-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043388-A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) PTPRO, PTPRE, PTPRZ1 GAA 2360/4885HTT 385/4885ALDH1A1 774/4885
US-20100168101-A1 OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) PTPRO, PTPRE, PTPRZ1 GAA 2377/4885HTT 402/4885ALDH1A1 798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.